Your session is about to expire
← Back to Search
Behavioural Intervention
EPIC-P for HIV/AIDS
N/A
Waitlist Available
Led By Roman Shrestha, PhD, MPH
Research Sponsored by University of Connecticut
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 6 months
Awards & highlights
Study Summary
This trial will assess the feasibility and acceptability of an HIV prevention intervention among high-risk people who inject drugs, as well as its preliminary efficacy in terms of increasing adherence to PrEP and primary HIV prevention.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Retention Rate
Secondary outcome measures
Acceptability
HIV Incidence
PrEP Adherence DBS
+2 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: EPIC-PExperimental Treatment1 Intervention
Participants will enroll in a bio-behavioral intervention aimed at preventing HIV transmission in people who inject drugs.
Find a Location
Who is running the clinical trial?
University of ConnecticutLead Sponsor
184 Previous Clinical Trials
158,193 Total Patients Enrolled
Gilead SciencesIndustry Sponsor
1,084 Previous Clinical Trials
848,379 Total Patients Enrolled
Roman Shrestha, PhD, MPHPrincipal Investigator - Associate Research Scientist, Yale School of Medicine
University of Connecticut
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this research undertaking currently open to new participants?
"Clinicaltrials.gov reports that this medical experiment, which was initially made visible on September 15th 2020, is no longer taking partipants. However, there are 238 other trials that are still open to enrollees at the present moment."
Answered by AI
Share this study with friends
Copy Link
Messenger